Kyverna Therapeutics Inc (KYTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -123,503 | -86,716 | -44,635 | -127,477 | -89,988 |
| Depreciation Amortization | 1,431 | 1,016 | 501 | 2,133 | 1,570 |
| Accounts payable and accrued liabilities | -1,608 | 5,193 | 3,784 | 736 | 6,034 |
| Other Working Capital | -2,810 | 6,043 | -2,184 | 7,857 | 7,823 |
| Other Operating Activity | 6,305 | -2,400 | -2,381 | 2,501 | -2,628 |
| Operating Cash Flow | $-120,185 | $-76,864 | $-44,915 | $-114,250 | $-77,189 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 57,828 | 34,949 | 5,578 | -158,697 | -188,451 |
| PPE Investments | 64 | -4 | N/A | -2,205 | -1,673 |
| Other Investing Activity | -590 | -200 | 0 | 0 | 0 |
| Investing Cash Flow | $57,302 | $34,745 | $5,578 | $-160,902 | $-190,124 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -723 | -603 | -341 | -956 | -709 |
| Common Stock Issued | 1,654 | 3 | 3 | 341,430 | 341,398 |
| Other Financing Activity | -506 | -463 | -76 | -3,361 | -3,361 |
| Financing Cash Flow | $425 | $-1,063 | $-414 | $337,113 | $337,328 |
| Beginning Cash Position | 97,173 | 97,173 | 97,173 | 35,212 | 35,212 |
| End Cash Position | 34,715 | 53,991 | 57,422 | 97,173 | 105,227 |
| Net Cash Flow | $-62,458 | $-43,182 | $-39,751 | $61,961 | $70,015 |
| Free Cash Flow | |||||
| Operating Cash Flow | -120,185 | -76,864 | -44,915 | -114,250 | -77,189 |
| Capital Expenditure | -6 | -4 | N/A | -2,205 | -1,673 |
| Free Cash Flow | -120,191 | -76,868 | -44,915 | -116,455 | -78,862 |